-68.3%
TTD vs MRNA
+485.7%
-554.0%
-75.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.6% | +5.4% | -2.7% | +2.6% |
| 7D | -0.6% | -1.1% | +0.5% | -0.6% |
| 30D | +6.3% | +126.1% | -119.8% | +4.2% |
| 3M | -24.1% | +190.0% | -214.2% | -26.6% |
| 6M | -47.4% | +157.2% | -204.7% | -48.5% |
| YTD | -62.2% | +388.2% | -450.4% | -66.3% |
| 1Y | -68.3% | +467.0% | -535.3% | -72.4% |
| All | -68.3% | +485.7% | -554.0% | -72.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling